The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Gene Editing-Global Market Insights and Sales Trends 2025
Synopsis
Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
The global Gene Editing market size is expected to reach US$ 5441.3 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Gene Editing in various end use industries. The expanding demands from the Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Contract Research Organizations,, are propelling Gene Editing market. Zinc finger nucleases (ZFNs), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transcription Activator-Like Effector-based Nucleases (TALENs) segment is estimated at % CAGR for the next seven-year period.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Editing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Editing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Editing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Editing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Editing covered in this report include Thermo Fisher Scientific, Merck, Horizon Discovery, Sangamo BioSciences, Integrated DNA Technologies, Lonza, New England Biolabs, OriGene Technologies and Transposagen Biopharmaceuticals, etc.
The global Gene Editing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Merck
Horizon Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
Global Gene Editing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Editing market, Segment by Type:
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
Global Gene Editing market, by Application
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Editing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
The global Gene Editing market size is expected to reach US$ 5441.3 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Gene Editing in various end use industries. The expanding demands from the Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Contract Research Organizations,, are propelling Gene Editing market. Zinc finger nucleases (ZFNs), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transcription Activator-Like Effector-based Nucleases (TALENs) segment is estimated at % CAGR for the next seven-year period.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Gene Editing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Gene Editing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Gene Editing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Gene Editing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Gene Editing covered in this report include Thermo Fisher Scientific, Merck, Horizon Discovery, Sangamo BioSciences, Integrated DNA Technologies, Lonza, New England Biolabs, OriGene Technologies and Transposagen Biopharmaceuticals, etc.
The global Gene Editing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Merck
Horizon Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
Global Gene Editing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Gene Editing market, Segment by Type:
Zinc finger nucleases (ZFNs)
Transcription Activator-Like Effector-based Nucleases (TALENs)
CRISPR-Cas system
Global Gene Editing market, by Application
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Gene Editing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Gene Editing
1.1 Gene Editing Market Overview
1.1.1 Gene Editing Product Scope
1.1.2 Gene Editing Market Status and Outlook
1.2 Global Gene Editing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gene Editing Market Size by Region (2018-2029)
1.4 Global Gene Editing Historic Market Size by Region (2018-2023)
1.5 Global Gene Editing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gene Editing Market Size (2018-2029)
1.6.1 North America Gene Editing Market Size (2018-2029)
1.6.2 Europe Gene Editing Market Size (2018-2029)
1.6.3 Asia-Pacific Gene Editing Market Size (2018-2029)
1.6.4 Latin America Gene Editing Market Size (2018-2029)
1.6.5 Middle East & Africa Gene Editing Market Size (2018-2029)
2 Gene Editing Market by Type
2.1 Introduction
2.1.1 Zinc finger nucleases (ZFNs)
2.1.2 Transcription Activator-Like Effector-based Nucleases (TALENs)
2.1.3 CRISPR-Cas system
2.2 Global Gene Editing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gene Editing Historic Market Size by Type (2018-2023)
2.2.2 Global Gene Editing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gene Editing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gene Editing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gene Editing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gene Editing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gene Editing Revenue Breakdown by Type (2018-2029)
3 Gene Editing Market Overview by Application
3.1 Introduction
3.1.1 Biotechnology & Pharmaceutical Companies
3.1.2 Academic & Government Research Institutes
3.1.3 Contract Research Organizations
3.2 Global Gene Editing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gene Editing Historic Market Size by Application (2018-2023)
3.2.2 Global Gene Editing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gene Editing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gene Editing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gene Editing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gene Editing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gene Editing Revenue Breakdown by Application (2018-2029)
4 Gene Editing Competition Analysis by Players
4.1 Global Gene Editing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Editing as of 2022)
4.3 Date of Key Players Enter into Gene Editing Market
4.4 Global Top Players Gene Editing Headquarters and Area Served
4.5 Key Players Gene Editing Product Solution and Service
4.6 Competitive Status
4.6.1 Gene Editing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Gene Editing Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Gene Editing Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Gene Editing Products, Services and Solutions
5.2.4 Merck Gene Editing Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Horizon Discovery
5.3.1 Horizon Discovery Profile
5.3.2 Horizon Discovery Main Business
5.3.3 Horizon Discovery Gene Editing Products, Services and Solutions
5.3.4 Horizon Discovery Gene Editing Revenue (US$ Million) & (2018-2023)
5.3.5 Sangamo BioSciences Recent Developments
5.4 Sangamo BioSciences
5.4.1 Sangamo BioSciences Profile
5.4.2 Sangamo BioSciences Main Business
5.4.3 Sangamo BioSciences Gene Editing Products, Services and Solutions
5.4.4 Sangamo BioSciences Gene Editing Revenue (US$ Million) & (2018-2023)
5.4.5 Sangamo BioSciences Recent Developments
5.5 Integrated DNA Technologies
5.5.1 Integrated DNA Technologies Profile
5.5.2 Integrated DNA Technologies Main Business
5.5.3 Integrated DNA Technologies Gene Editing Products, Services and Solutions
5.5.4 Integrated DNA Technologies Gene Editing Revenue (US$ Million) & (2018-2023)
5.5.5 Integrated DNA Technologies Recent Developments
5.6 Lonza
5.6.1 Lonza Profile
5.6.2 Lonza Main Business
5.6.3 Lonza Gene Editing Products, Services and Solutions
5.6.4 Lonza Gene Editing Revenue (US$ Million) & (2018-2023)
5.6.5 Lonza Recent Developments
5.7 New England Biolabs
5.7.1 New England Biolabs Profile
5.7.2 New England Biolabs Main Business
5.7.3 New England Biolabs Gene Editing Products, Services and Solutions
5.7.4 New England Biolabs Gene Editing Revenue (US$ Million) & (2018-2023)
5.7.5 New England Biolabs Recent Developments
5.8 OriGene Technologies
5.8.1 OriGene Technologies Profile
5.8.2 OriGene Technologies Main Business
5.8.3 OriGene Technologies Gene Editing Products, Services and Solutions
5.8.4 OriGene Technologies Gene Editing Revenue (US$ Million) & (2018-2023)
5.8.5 OriGene Technologies Recent Developments
5.9 Transposagen Biopharmaceuticals
5.9.1 Transposagen Biopharmaceuticals Profile
5.9.2 Transposagen Biopharmaceuticals Main Business
5.9.3 Transposagen Biopharmaceuticals Gene Editing Products, Services and Solutions
5.9.4 Transposagen Biopharmaceuticals Gene Editing Revenue (US$ Million) & (2018-2023)
5.9.5 Transposagen Biopharmaceuticals Recent Developments
5.10 Editas Medicine
5.10.1 Editas Medicine Profile
5.10.2 Editas Medicine Main Business
5.10.3 Editas Medicine Gene Editing Products, Services and Solutions
5.10.4 Editas Medicine Gene Editing Revenue (US$ Million) & (2018-2023)
5.10.5 Editas Medicine Recent Developments
5.11 CRISPR Therapeutics
5.11.1 CRISPR Therapeutics Profile
5.11.2 CRISPR Therapeutics Main Business
5.11.3 CRISPR Therapeutics Gene Editing Products, Services and Solutions
5.11.4 CRISPR Therapeutics Gene Editing Revenue (US$ Million) & (2018-2023)
5.11.5 CRISPR Therapeutics Recent Developments
5.12 RGen Solutions
5.12.1 RGen Solutions Profile
5.12.2 RGen Solutions Main Business
5.12.3 RGen Solutions Gene Editing Products, Services and Solutions
5.12.4 RGen Solutions Gene Editing Revenue (US$ Million) & (2018-2023)
5.12.5 RGen Solutions Recent Developments
5.13 Sigma-Aldrich
5.13.1 Sigma-Aldrich Profile
5.13.2 Sigma-Aldrich Main Business
5.13.3 Sigma-Aldrich Gene Editing Products, Services and Solutions
5.13.4 Sigma-Aldrich Gene Editing Revenue (US$ Million) & (2018-2023)
5.13.5 Sigma-Aldrich Recent Developments
5.14 GeneCopoeia
5.14.1 GeneCopoeia Profile
5.14.2 GeneCopoeia Main Business
5.14.3 GeneCopoeia Gene Editing Products, Services and Solutions
5.14.4 GeneCopoeia Gene Editing Revenue (US$ Million) & (2018-2023)
5.14.5 GeneCopoeia Recent Developments
5.15 Genscript Biotech
5.15.1 Genscript Biotech Profile
5.15.2 Genscript Biotech Main Business
5.15.3 Genscript Biotech Gene Editing Products, Services and Solutions
5.15.4 Genscript Biotech Gene Editing Revenue (US$ Million) & (2018-2023)
5.15.5 Genscript Biotech Recent Developments
6 North America
6.1 North America Gene Editing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Gene Editing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gene Editing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gene Editing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gene Editing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gene Editing Market Dynamics
11.1 Gene Editing Industry Trends
11.2 Gene Editing Market Drivers
11.3 Gene Editing Market Challenges
11.4 Gene Editing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
